IP Library › Granted Patent US 12,721,950
Granted Patent B2
US 12,721,950 · App. 18/553,644 · Granted Sep 1, 2026

Medicament delivery member modules

Inventor: Ming-Ting Yin (Taoyuan City, TW)
Assignee: SHL Medical AG
A61M5/3202A61M5/3245A61M2005/3254
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,721,950
App. No.
18/553,644
Granted
Sep 1, 2026
Kind
B2
Abstract

A medicament delivery member module (to) for a medicament delivery device is disclosed, the medicament delivery member module (to) comprising a proximal shield ( 30 ), a distal shield ( 50 ) and a medicament delivery member hub ( 70 ), and the medicament delivery member module ( 10 ) extending along a longitudinal axis ( 12 ) in an axial direction ( 13 ) from a proximal end ( 14 ) to a distal end ( 15 ). The proximal shield ( 30 ) comprises a first surface ( 31 ) facing towards the longitudinal axis ( 12 ) and a second surface ( 32 ) facing away from the longitudinal axis ( 12 ). The medicament delivery member hub ( 70 ) comprises a third surface ( 73 ) facing away from the longitudinal axis ( 12 ) and the distal shield ( 50 ) comprises a fourth surface ( 54 ) facing towards the longitudinal axis. The proximal shield ( 30 ) is moveable in the axial direction ( 13 ) relative to the distal shield ( 50 ) from a proximal position to a distal position.

Claims (29)

1 . A medicament delivery member module ( 10 ) for a medicament delivery device, the medicament delivery member module ( 10 ) comprising a proximal shield ( 30 ), a distal shield ( 50 ) and a medicament delivery member hub ( 70 ), the medicament delivery member module ( 10 ) extending along a longitudinal axis ( 12 ) in an axial direction ( 13 ) from a proximal end ( 14 ) to a distal end ( 15 ),

wherein the proximal shield ( 30 ) comprises a first surface ( 31 ) facing towards the longitudinal axis ( 12 ) and a second surface ( 32 ) facing away from the longitudinal axis ( 12 ),

wherein the medicament delivery member hub ( 70 ) comprises a third surface ( 73 ) facing away from the longitudinal axis ( 12 ) and the distal shield ( 50 ) comprises a fourth surface ( 54 ) facing towards the longitudinal axis,

wherein the proximal shield ( 30 ) is moveable in the axial direction ( 13 ) relative to the distal shield ( 50 ) from a proximal position to a distal position,

wherein the medicament delivery member module ( 10 ) is arranged so that in a first part of a movement of the proximal shield ( 30 ) from the proximal position to the distal position,

the first surface ( 31 ) and the third surface ( 73 ) are in contact with one another and the second surface ( 32 ) and the fourth surface ( 54 ) are in contact with one another, and the friction between the first surface ( 31 ) and the third surface ( 73 ) is greater than the friction between the second surface ( 32 ) and the fourth surface ( 54 ),

so that during the first part of the movement of the proximal shield ( 30 ) from the proximal position to the distal position, the medicament delivery member hub ( 70 ) moves with the proximal shield ( 30 ),

wherein the medicament delivery member module ( 10 ) is arranged so that in a subsequent part of the movement of the proximal shield ( 30 ) from the proximal position to the distal position,

the first surface ( 31 ) and the third surface ( 73 ) are in contact with one another and the second surface ( 32 ) and the fourth surface ( 54 ) are spaced apart from one another, and

the medicament delivery member hub ( 70 ) is restricted from further movement in the distal direction,

so that the proximal shield ( 30 ) moves in the distal direction relative to both the distal shield ( 50 ) and the medicament delivery member hub ( 70 ) during the subsequent part of the movement of the proximal shield ( 30 ) from the proximal position to the distal position.

2 . The medicament delivery member module ( 10 ) of claim 1 , wherein the first surface and the second surface are both on a protrusion ( 36 ).

3 . The medicament delivery member module of claim 2 , wherein the protrusion ( 36 ) is compressible.

4 . The medicament delivery member module ( 10 ) of claim 2 , wherein the protrusion ( 36 ) is on a tab of the proximal shield ( 30 ).

5 . The medicament delivery member module ( 10 ) of claim 1 , wherein the third surface ( 73 ) comprises a protrusion ( 74 ).

6 . The medicament delivery member module of claim 5 , wherein the protrusion ( 74 ) is a rib that extends circumferentially around the longitudinal axis ( 12 ).

7 . The medicament delivery member module ( 10 ) of claim 1 , wherein the third surface comprises a plurality of protrusions ( 74 ) that are spaced apart from one another in the axial direction.

8 . The medicament delivery member module ( 10 ) of claim 7 , wherein the plurality of protrusions ( 74 ) are ribs that extend circumferentially around the longitudinal axis ( 12 ).

9 . The medicament delivery member module ( 10 ) of claim 1 , wherein the proximal shield ( 30 ) is arranged telescopically inside the distal shield ( 50 ).

10 . The medicament delivery member module ( 10 ) of claim 1 , wherein the proximal shield ( 30 ) is moveable in the axial direction ( 13 ) relative to the distal shield ( 50 ) from an initial position to the proximal position,

wherein in the initial position, the first surface ( 31 ) and the third surface ( 73 ) are in contact with one another and the second surface ( 32 ) and the fourth surface ( 54 ) are spaced apart from one another, and

wherein the medicament delivery member module ( 10 ) is arranged so that the proximal shield ( 30 ) and the medicament delivery member hub ( 70 ) move in the distal direction relative to the distal shield ( 50 ) when the medicament delivery member module ( 10 ) moves from the initial position to the proximal position.

11 . The medicament delivery member module ( 10 ) of claim 1 , wherein the distal shield ( 50 ) comprises a fifth surface ( 55 ), wherein the fifth surface ( 55 ) faces in the proximal direction, and wherein the medicament delivery member hub ( 70 ) comprises a sixth surface ( 76 ), wherein the sixth surface ( 76 ) faces in the distal direction, and

wherein the fifth surface ( 55 ) is arranged to be in contact with the sixth surface ( 76 ) during the subsequent part of the movement stroke so that the medicament delivery member hub ( 70 ) is restricted from further movement in the distal direction during the subsequent part of the movement stroke.

12 . A sub-assembly of a medicament delivery device comprising a cartridge and the medicament delivery member module ( 10 ) of claim 1 .

13 . The sub-assembly of claim 12 , wherein the cartridge comprises a fifth surface, wherein the fifth surface faces in the proximal direction, and wherein the medicament delivery member hub ( 70 ) comprises a sixth surface ( 76 ), wherein the sixth surface ( 76 ) faces in the distal direction, and

wherein the fifth surface is arranged to be in contact with the sixth surface ( 76 ) during the subsequent part of the movement stroke so that the medicament delivery member hub ( 70 ) is restricted from further movement in the distal direction during the subsequent part of the movement stroke.

14 . A cartridge assembly for attaching to a powerpack of a medicament delivery device, the cartridge assembly comprising the medicament delivery member module ( 10 ) of claim 1 .

15 . A medicament delivery device comprising the medicament delivery member module ( 10 ) of claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2023
From: YIN, MING-TING
To: SHL MEDICAL AG
Reel/Frame 065130/0173 →
Continuity (2)
Provisional Application 63193133 · May 26, 2021
Related Publication 20240181170A1 · Jun 6, 2024
References Cited (53)
US 8932254B2 · Eaton · 2015 [cited by applicant]
US 9757521B2 · McLoughlin et al. · 2017 [cited by applicant]
US 10300213B2 · Bengtsson et al. · 2019 [cited by applicant]
US 10561793B2 · Finke et al. · 2020 [cited by applicant]
US 10874800B2 · Schader et al. · 2020 [cited by applicant]
US 11007327B2 · Bengtsson et al. · 2021 [cited by applicant]
US 20030120209A1 · Jensen · 2003 [cited by examiner]
US 20070021718A1 · Burren et al. · 2007 [cited by applicant]
US 20080177237A1 · Stonehouse · 2008 [cited by examiner]
US 20100042047A1 · Suzuki · 2010 [cited by examiner]
US 20130237905A1 · Holmqvist · 2013 [cited by examiner]
US 20140163518A1 · Epstein · 2014 [cited by examiner]
US 20150157807A1 · Srinivasan · 2015 [cited by examiner]
US 20150273161A1 · Bengtsson et al. · 2015 [cited by applicant]
US 20150320939A1 · Beek · 2015 [cited by examiner]
US 20180161504A1 · Kemp et al. · 2018 [cited by applicant]
US 20180169338A1 · Mosebach et al. · 2018 [cited by applicant]
US 20180353709A1 · Schader et al. · 2018 [cited by applicant]
US 20200129699A1 · Helmer · 2020 [cited by applicant]
US 20200188605A1 · Boström · 2020 [cited by applicant]
US 20200282151A1 · Liscio · 2020 [cited by applicant]
US 20200338277A1 · Franke et al. · 2020 [cited by applicant]
US 20200360621A1 · Franke et al. · 2020 [cited by applicant]
US 20200376200A1 · Zucker et al. · 2020 [cited by applicant]
US 20210178082A1 · Franke · 2021 [cited by examiner]
US 20220023549A1 · Whyte · 2022 [cited by examiner]
US 20220111155A1 · Py · 2022 [cited by examiner]
US 20230355892A1 · Calderwood · 2023 [cited by examiner]
CN 102971024A · 2013 [cited by applicant]
CN 112512611A · 2021 [cited by applicant]
EP 2021054B1 · 2010 [cited by applicant]
EP 2346552B1 · 2012 [cited by applicant]
EP 2875838A1 · 2015 [cited by applicant]
EP 2892590B1 · 2018 [cited by applicant]
EP 3302630A1 · 2018 [cited by applicant]
EP 3302635A1 · 2018 [cited by applicant]
EP 3360591A1 · 2018 [cited by applicant]
EP 3380134A1 · 2018 [cited by applicant]
EP 3492126A1 · 2019 [cited by applicant]
EP 3569271A1 · 2019 [cited by applicant]
EP 3727502A1 · 2020 [cited by applicant]
EP 3727516A1 · 2020 [cited by applicant]
EP 3823701A1 · 2021 [cited by applicant]
GB 2467904A · 2010 [cited by applicant]
WO WO2009094793A1 · 2009 [cited by applicant]
WO WO2015185664A1 · 2015 [cited by applicant]
WO WO2020070327A1 · 2020 [cited by applicant]
WO WO2020104812A1 · 2020 [cited by applicant]
WO WO2020169842A1 · 2020 [cited by applicant]
WO WO2022128520A1 · 2022 [cited by applicant]
International Search Report received for International Application No. PCT/EP2022/057526, mailed on Jul. 27, 2022, 3 pages. [cited by applicant]
Written Opinion of the International Searching Authority received for International Application No. PCT/EP2022/057526, mailed on Jul. 7, 2022, 4 pages. [cited by applicant]
Chinese Application No. 202280036138, First Office Action mailed Apr. 9, 2026. [cited by applicant]